Blog

Arturo LoAIza-Bonilla

Apr 24, 2025, 14:10

Arturo Loaiza-Bonilla to Present at ASCO/ESMO Joint Session on Biomarker-Driven Therapeutics

Arturo Loaiza-Bonilla, Systemwide Chief of Hematology and Oncology at St. Luke’s University Health Network, shared on LinkedIn:

“American Society of Clinical Oncology (ASCO) abstracts and Program released today!

Absolutely thrilled to be presenting at the ASCO/ESMO – European Society for Medical Oncology Joint Session: Biomarker-Driven Therapeutics: Translating Innovation Into Practice. Featuring Dr. Robin Zon (ASCO President), Dr. Fabrice Andre (ESMO President), Dr. Benedikt Westphalen (ESMO Chair PM WG), Dr. Julie Gralow (ASCO CMO), Dr. Teresa Amaral (ESMO Chair of the Leadership Dvpt Cmt) and I (St. Luke’s University Health Network and Massive Bio).

See you in Chicago!”

Arturo Loaiza-Bonilla will join global oncology leaders at ASCO 2025, presenting in the ASCO/ESMO Joint Session titled ‘Biomarker-Driven Therapeutics: Translating Innovation Into Practice.’ The session will also feature contributions from ASCO and ESMO leadership, highlighting global perspectives on integrating biomarker science into oncology practice.

ASCO2025 Benedikt Westphalen biomarker therapeutics cancer cancer innovation ESMO Fabrice Andre Julie Gralow OncoDaily Oncology Precision Oncology Robin Zon Teresa Amaral

Senate President Passes Away After Brave Battle with Cancer: Dominick J. Ruggerio

Where to Study to Become ASCO President: 2025 Institutional Rankings

Yelak Biru: UK grants first approval for Blenrep in multiple myeloma

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

Dr. Don Dizon and Dr. Nathan Pennell Reflect on the Evolution of the ASCO Educational Book